Ashland
The position involves bioprocessing and manufacturing of proteins, including therapeutic proteins and antibodies, at lab and pilot scale. It includes process development, scale-up, formulation development, and collaboration in a scientific environment, focusing on biologic analysis and process optimization.
Headquarters
Wilmington, Delaware, United States
Company Size
1001-5000 employees
Founded
1924
Ashland Global Holdings Inc. (NYSE: ASH) is a premier specialty materials company with a conscious and proactive mindset for sustainability. The company serves customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ashland.
45% below the average for this role
Morgan Stanley Adjusts Ashland Inc. (ASH) Model Following Fiscal Q1 Results
3 weeks ago
Lead - Formulation & DP - Biosimilars
drreddyslaboratorieslimited.com
Senior Scientist, Downstream Process Development
Elanco
Senior Manufacturing Process Scientist
Integrated Resources INC
Lead - Formulation & DP
drreddyslaboratorieslimited.com
Associate Scientific Director / Principal Scientist — Downstream Processing and Manufacturability Assessment
Syngene International Limited
Senior Research Associate
Syngene International Limited